A collaborative agreement to develop commercial relationships to serve unmet needs by utilizing the Symphony Platform in the blood and hospital markets
WEST WARWICK, Rhode Island
February 14, 2023
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), and Blood Centers of America (BCA) today announced that they have executed a collaborative agreement to develop commercial relationships to serve unmet needs by utilizing the Symphony Platform in the blood and hospital markets.
As part of the agreement, Bluejay will be recognized as a strategic partner of BCA member organizations, with BCA referring strategic group purchasing organization (GPO) partners and BCA’s member blood centers to Bluejay. Bluejay gains access to BCA members and their network to offer them Bluejay’s innovative solutions. The collaboration also provides opportunities to support clinical studies and explore direct applications for Symphony in the blood supply industry.
“Bluejay and BCA share the strategic vision of addressing the dire, time-sensitive needs of patients in critical care settings,” said Neil Dey, CEO of Bluejay Diagnostics. “This agreement allows us to leverage relationships BCA members have cultivated within their vast hospital network by providing access to new markets under the BCA umbrella.”
“BCA is excited to partner with Bluejay to bring innovation that helps support the sustainability of the blood supply,” said Bill Block, President and CEO of Blood Centers of America, Inc. “Symphony and its products will bring critical care closer to the community, something not previously possible.”About Blood Centers of America
Blood Centers of America (BCA) is a member-owned organization comprised of over 50 independent blood centers throughout the North America, representing nearly 40% of the U.S. blood supply. Along with their core business of providing a substantial portion of U.S. blood supply, other BCA member services include patient blood management, transfusion services, immunohematology testing, therapeutic apheresis and tissue and cord blood banking. In addition, BCA members provide a variety of human blood products, cells and tissues to the therapeutic, diagnostic and cell therapy industries.
BACK TO UPDATES